Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality
暂无分享,去创建一个
G. Lip | S. Perrella | G. d’Ettorre | C. Miele | F. Cipollone | F. Violi | M. Mancone | C. D’agostino | P. Guariglia | G. Lip | M. Rocco | F. Pacini | Valentina Perri | M. Lichtner | C. Mastroianni | F. Pugliese | M. Pirro | R. Cangemi | C. Ricci | M. de Angelis | A. Oliva | L. Celani | Letizia Santinelli | G. Ceccarelli | D. D’Ardes | L. Titi | Francesco De Lazzaro | G. Giordano | G. Russo | M. Ciardi | Gabriella De Girolamo | P. Vassalini | Claudia Pinacchio | C. Manganelli | P. Pignatelli | F. Ruberto | F. Alessandri | D. Ferro | Francesco Francesco Franco Alida Daniela Francesco Daniela C Pugliese Alessandri Ruberto Albante Aur | A. Albante | D. Auricchio | Daniela M. De Lauri | Carmela Di Santo | S. Ianni | E. Magnanimi | Fabiola Ratini | A. Sabani | P. Vaccaro | K. Bruno | P. Celli | Stella Consolo | C. Croce | L. Giannetti | S. Martelli | T. Messina | Elisa Pattelli | M. Portieri | N. Almenrader | R. Arzilla | E. Delia | C. Di Giovanni | A. Laderchi | Carlotta Macrì | M. Marandola | Giada Nardecchia | M. Pacilli | Fabio Silvio Mario Araimo Morselli | C. Imperiale | P. Tordiglione | C. Ajassa | V. Trinchieri | L. Antonelli | Rosaria Maria Cuomo | M. Carnevalini | C. Mastropietro | G. Iaiani | I. Mezzaroma | M. Falciano | A. Brogi | N. Cavallari | Marco Rivano Capparuccia | A. Massetti | C. Fimiani | M. Santori | Alessandro Bianchi | C. Franchi | Maurizio De Angelis | S. Sereno | C. Furlan | G. D. De Sanctis | F. Paoletti | P. Pasculli | F. Cogliati Dezza | F. Cancelli | G. Savelloni | S. Valeri | G. Siccardi | Federica Alessi | G. Recchia | M. Ridolfi | F. Romani | R. Aronica | V. Filippi | Mauro Vera | Lorenzo Volpicelli | Matteo Candy | Rugova Alban | S. Di Bari | Francesca Gavaruzzi | E. Casali | Maria Serena Carli | A. Zingaropoli | M. De Angelis | P. Nijhawan | Pietro Giuseppe Innocenti | F. Mengoni | Alessandro Bianchi | C. Ricci | Francesco Pugliese | Serena Perrella | C. D'Agostino | Daniela M. De Lauri | Carmela Di Santo | Massimo Mancone | Carlotta Macrì | Giada Nardecchia | Rosaria Maria Cuomo | L. Volpicelli | F. Gavaruzzi | Maria Serena Carli | Pietro Giuseppe Innocenti | Martina Carnevalini | Alessandra Oliva | Francesco Alessandri | C. Mastroianni | S. Perrella | Francesco Pugliese | M. Carli | P. G. Innocenti
[1] G. d’Ettorre,et al. Nox2 activation in Covid-19 , 2020, Redox Biology.
[2] N. Mackman,et al. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[3] F. Cipollone,et al. IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ? , 2020, Antioxidants & redox signaling.
[4] G. d’Ettorre,et al. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19. , 2020, Circulation research.
[5] F. Violi,et al. SARS-CoV-2 and myocardial injury: a role for Nox2? , 2020, Internal and Emergency Medicine.
[6] M. Aepfelbacher,et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.
[7] F. Violi,et al. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge , 2020, Thrombosis and Haemostasis.
[8] Yutao Guo,et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.
[9] B. Song,et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review , 2020, European Radiology.
[10] M. Humbert,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .
[11] B. Nordestgaard,et al. Plasma Albumin and Incident Cardiovascular Disease , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[12] A. Farcomeni,et al. Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis , 2019, Internal and Emergency Medicine.
[13] F. Violi,et al. Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia. , 2019, The American journal of cardiology.
[14] M. Humbert,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.
[15] Robert A. Campbell,et al. TNF-alpha driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. , 2019, Blood.
[16] G. Corazza,et al. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis , 2019, Hepatology communications.
[17] O. Barbarash,et al. FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION , 2018, Fundamental and Clinical Medicine.
[18] Jeroen J. Bax,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Circulation.
[19] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[20] F. Violi,et al. Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly. , 2017, Antioxidants & redox signaling.
[21] Marco Falcone,et al. Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] F. Violi,et al. Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia. , 2016, The Journal of infection.
[23] Marc P. Bonaca,et al. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis–Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50) , 2016, Circulation.
[24] A. Hoes,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.
[25] F. Violi,et al. Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events. , 2015, The American journal of cardiology.
[26] A. Farcomeni,et al. Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia , 2015, Thorax.
[27] V. Chair,et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.
[28] A. Hoes,et al. [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.
[29] Shah Ebrahim,et al. JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .
[30] G. FitzGerald,et al. HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Vitamin E Reduces Monocyte Tissue Factor Expression in Cirrhotic Patients , 1999 .
[31] A. U. Rickel,et al. Guidelines for Prevention, I , 1998 .